Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
4 years ago

Inhibition of fosfomycin resistance protein FosA by phosphonoformate (foscarnet) in multidrug-resistant Gram-negative pathogens.

Sluis-Cremer, Mettus, McElheny, Ito, Tomich, Doi
FosA proteins confer fosfomycin resistance in Gram-negative pathogens via glutathione-mediated modification of the antibiotic. In this study, we assessed whether inhibition of FosA by sodium phosphonoformate (PPF; foscarnet), a clinically approved antiviral agent, would reverse fosfomycin resistance in representative Gram-negative pathogens. The inhibitory activity of PPF against purified recombinant FosA from Escherichia coli (FosA3), Klebsiella pneumoniae (FosA(KP)), Enterobacter cloacae (FosA(EC)) and Pseudomonas aeruginosa (FosA(PA)) was determined by steady-state kinetics. The antibacterial activity of PPF against FosA was evaluated by susceptibility testing and time-kill assays in clinical strains of these species. PPF increased the Michaelis constant Km for fosfomycin in a dose dependent manner without impacting the maximum rate of the reaction (Vmax) for all four FosA enzymes tested, denoting a competitive mechanism of inhibition. Inhibitory constants (Ki ) were 22.6, 35.8, 24.4 and 56.3 μM for FosA(KP), FosA(EC), FosA(PA) and FosA3, respectively. Addition of clinically achievable concentrations of PPF (∼667 μM) reduced the MICs of fosfomycin by ≥4-fold among 52% of K. pneumoniae, E. cloacae and P. aeruginosa clinical strains tested and lead to a bacteriostatic or bactericidal effect in time-kill assays among representative strains. PPF inhibits FosA activity across Gram-negative species, and can potentiate fosfomycin activity against the majority of strains with chromosomally encoded fosA These data suggest that PPF may be repurposed as an adjuvant for fosfomycin to treat infections caused by some of FosA-producing, multidrug-resistant Gram-negative pathogens.

Publisher URL: http://doi.org/10.1128/AAC.01424-17

DOI: 10.1128/AAC.01424-17

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.